Interventions Designed to Increase the Uptake of Lung Cancer Screening: An Equity-Oriented Scoping Review.

Equity-oriented lung cancer screening framework Health equity Lung cancer screening Priority population Scoping review

Journal

JTO clinical and research reports
ISSN: 2666-3643
Titre abrégé: JTO Clin Res Rep
Pays: United States
ID NLM: 101769967

Informations de publication

Date de publication:
Mar 2023
Historique:
received: 14 09 2022
revised: 17 01 2023
accepted: 23 01 2023
entrez: 20 3 2023
pubmed: 21 3 2023
medline: 21 3 2023
Statut: epublish

Résumé

Participation in lung cancer screening (LCS) is lower in populations with the highest burden of lung cancer risk (through the social patterning of smoking behavior) and lowest levels of health care utilization (through structurally inaccessible care) leading to a widening of health inequities. We conducted a scoping review using the Arksey and O'Malley methodological framework to inform equitable access to LCS by illuminating knowledge and implementation gaps in interventions designed to increase the uptake of LCS. We comprehensively searched for LCS interventions (Ovid Medline, Excerpta Medica database, the Cochrane Library, Cumulative Index to Nursing and Allied Health Literature, and Scopus from 2000 to June 22, 2021) and included peer-reviewed articles and gray literature published in the English language that describe an intervention designed to increase the uptake of LCS, charted data using our previously published tool and conduced a health equity analysis to determine the intended-unintended and positive-negative outcomes of the interventions for populations experiencing the greatest inequities. Our search yielded 3572 peer-reviewed articles and 54,292 pieces of gray literature. Ultimately, we included 35 peer-reviewed articles and one gray literature. The interventions occurred in the United States, United Kingdom, Japan, and Italy, focusing on shared decision-making, the use of electronic health records as reminders, patient navigation, community-based campaigns, and mobile computed tomography scanners. We developed an equity-oriented LCS framework and mapped the dimensions and outcomes of the interventions on access to LCS on the basis of approachability, acceptability, availability, affordability, and appropriateness of the intervention. No intervention was mapped across all five dimensions. Most notably, knowledge and implementation gaps were identified in dimensions of acceptability, availability, and affordability. Interventions that were most effective in improving access to LCS targeted priority populations, raised community-level awareness, tailored materials for sociocultural acceptability, did not depend on prior patient engagement/registration with the health care system, proactively considered costs related to participation, and enhanced utilization through informed decision-making.

Identifiants

pubmed: 36938372
doi: 10.1016/j.jtocrr.2023.100469
pii: S2666-3643(23)00008-5
pmc: PMC10015251
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100469

Informations de copyright

© 2023 The Authors.

Références

Chest. 2020 Jan;157(1):236-238
pubmed: 31916962
Appl Clin Inform. 2019 Jan;10(1):19-27
pubmed: 30625501
Clin J Oncol Nurs. 2020 Aug 1;24(4):421-429
pubmed: 32678377
Am J Respir Crit Care Med. 2020 Apr 15;201(8):965-975
pubmed: 31825647
JAMA Intern Med. 2017 Mar 1;177(3):399-406
pubmed: 28135352
Lung Cancer. 2020 Oct;148:12-19
pubmed: 32771715
BMC Med Inform Decis Mak. 2018 Jan 12;18(1):5
pubmed: 29325548
Cancer Epidemiol. 2017 Feb;46:1-8
pubmed: 27866066
Clin Lung Cancer. 2021 Mar;22(2):83-91
pubmed: 33436279
N Engl J Med. 2011 Aug 4;365(5):395-409
pubmed: 21714641
J Cancer Educ. 2020 Aug;35(4):766-773
pubmed: 31069714
Am J Manag Care. 2018 Jun;24(6):272-277
pubmed: 29939501
JCO Clin Cancer Inform. 2017 Nov;1:1-6
pubmed: 30657381
BMC Fam Pract. 2021 Jan 7;22(1):10
pubmed: 33413135
Thorax. 2019 Jul;74(7):700-704
pubmed: 30420406
Lung Cancer. 2017 Mar;105:39-41
pubmed: 28236983
Ann Am Thorac Soc. 2019 Jun;16(6):744-751
pubmed: 31082267
Cochrane Database Syst Rev. 2012 Nov 14;11:MR000030
pubmed: 23152285
Cancer Nurs. 2021 Mar-Apr 01;44(2):89-97
pubmed: 31599751
PLoS One. 2021 May 6;16(5):e0251264
pubmed: 33956861
Int J Health Policy Manag. 2019 Sep 01;8(9):550-556
pubmed: 31657177
JAMA Intern Med. 2017 Mar 1;177(3):439-441
pubmed: 28135349
J Med Invest. 2012;59(1-2):127-35
pubmed: 22450001
Am J Med. 2014 Sep;127(9):813-6
pubmed: 24769298
Med Decis Making. 2019 Nov;39(8):950-961
pubmed: 31631776
Am J Prev Med. 2019 Aug;57(2):250-255
pubmed: 31248742
Chest. 2020 Oct;158(4):1742-1752
pubmed: 32439505
JAMA. 2021 Mar 09;325(10):962-970
pubmed: 33687470
Thorax. 2020 Apr;75(4):348-350
pubmed: 32127463
N Engl J Med. 2020 Feb 6;382(6):503-513
pubmed: 31995683
Ann Thorac Surg. 2020 Oct;110(4):1147-1152
pubmed: 32680629
Prev Med Rep. 2021 May 16;23:101397
pubmed: 34040933
JAMA Netw Open. 2020 Jan 3;3(1):e1920362
pubmed: 32003822
BMJ. 2014 Mar 07;348:g1687
pubmed: 24609605
Can Respir J. 2016;2016:3727689
pubmed: 27445531
BMC Public Health. 2021 Mar 19;21(1):538
pubmed: 33740928
J Am Coll Radiol. 2020 Feb;17(2):208-215
pubmed: 31499025
Ann Thorac Surg. 2022 Apr;113(4):1341-1347
pubmed: 33957098
Health Rep. 2015 Jun;26(6):12-20
pubmed: 26086335
Am J Public Health. 2008 Feb;98(2):216-21
pubmed: 18172133
Ann Intern Med. 2018 Oct 2;169(7):467-473
pubmed: 30178033
Health Expect. 2017 Feb;20(1):59-68
pubmed: 26701339
J Community Health. 2018 Feb;43(1):27-32
pubmed: 28612174
Eur Respir Rev. 2021 Jul 20;30(161):
pubmed: 34289983
Lung Cancer. 2019 Aug;134:66-71
pubmed: 31319997
Int J Equity Health. 2013 Mar 11;12:18
pubmed: 23496984
J Am Coll Radiol. 2020 May;17(5):606-612
pubmed: 31930983
Int J Equity Health. 2016 Oct 10;15(1):168
pubmed: 27724952
Health Expect. 2018 Aug;21(4):796-804
pubmed: 29473696
Cancer Med. 2018 Mar;7(3):894-902
pubmed: 29464877
Lancet. 2005 Oct 22-28;366(9495):1460-6
pubmed: 16243091
BMJ Open. 2021 Jul 28;11(7):e050056
pubmed: 34321305
Thorax. 2019 Apr;74(4):405-409
pubmed: 29440588
Chest. 2017 Mar;151(3):572-578
pubmed: 27815154
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
J Natl Cancer Inst. 2019 Apr 1;111(4):342-349
pubmed: 30698792
BMJ Open. 2015 Jul 14;5(7):e008254
pubmed: 26173719
Lancet Oncol. 2018 Jul;19(7):e344-e350
pubmed: 30084381
Chest. 2020 Nov;158(5):2200-2210
pubmed: 32562612
Res Involv Engagem. 2022 Apr 5;8(1):11
pubmed: 35382905
Thorax. 2019 Dec;74(12):1176-1178
pubmed: 31481631

Auteurs

Ambreen Sayani (A)

Women's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada.
MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada.

Muhanad Ahmed Ali (MA)

Women's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada.

Pooja Dey (P)

Women's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada.

Ann Marie Corrado (AM)

Peter Gilgan Centre for Women's Cancers, Women's College Hospital, Toronto, Ontario, Canada.

Carolyn Ziegler (C)

Library Services, Unity Health Toronto, Toronto, Ontario, Canada.

Erika Nicholson (E)

Canadian Partnership Against Cancer, Canada.

Aisha Lofters (A)

Women's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada.
MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada.
Peter Gilgan Centre for Women's Cancers, Women's College Hospital, Toronto, Ontario, Canada.
Institute for Clinical Evaluative Sciences (ICES), Toronto, Ontario, Canada.
Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada.
Department of Family Medicine, Women's College Hospital, Toronto, Ontario, Canada.
Dalla Lana School of Public Health, University of Toronto, Ontario, Canada.

Classifications MeSH